Alfalfa
Natural health product licensed in Canada
- Licence holder
- Nature's Ace Biopharmaceutical Inc.
- NPN or DIN-HM
- 80074441
- Status
- Active licence
- Licence date
- 14 December 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Medicago sativa Source : Sommité Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 2,500 milligramme | 500 milligramme | Not calculated |
| Medicago sativa Source : Sommité | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Gélatine, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine as a nutritive tonic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you have a history of systemic lupus erythematosus.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you are undergoing hormone replacement therapy or taking birth control medication.
Source
Official Health Canada record, licence 80074441
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.